about
Deciphering the molecular bases of the biological effects of antibodies against Interleukin-2: a versatile platform for fine epitope mapping.Fine epitope specificity of antibodies against interleukin-2 explains their paradoxical immunomodulatory effectsAntigenicity and immunogenicity of a synthetic oligosaccharide-protein conjugate vaccine against Haemophilus influenzae type b.Mathematical Models of the Impact of IL2 Modulation Therapies on T Cell DynamicsMolecular dissection of the interactions of an antitumor interleukin-2-derived mutein on a phage display-based platform.Effect of conjugation methodology on the immunogenicity and protective efficacy of meningococcal group C polysaccharide-P64k protein conjugates.Phagekines: Screening Binding Properties and Biological Activity of Functional Cytokines Displayed on Phages.Expression in Escherichia coli of the lpdA gene, protein sequence analysis and immunological characterization of the P64k protein from Neisseria meningitidis.Human IL-2 mutein with higher antitumor efficacy than wild type IL-2.Enzyme-linked immunosorbent assay for quantitative determination of capsular polysaccharide production in Streptococcus pneumoniae clinical isolates.Purified capsular polysaccharide of Neisseria meningitidis serogroup A as immune potentiator for antibody production.Recombinant Opc meningococcal protein, folded in vitro, elicits bactericidal antibodies after immunization.Comparison of three ELISA protocols to measure antibody responses elicited against serogroup C meningococcal polysaccharide in mouse, monkey and human seraMemory immune response generated inCercopithecus aethiopsagainst meningococcal polysaccharide serogroup C conjugate vaccineBlocking IL-2 Signal In Vivo with an IL-2 Antagonist Reduces Tumor Growth through the Control of Regulatory T Cells
P50
Q34213014-1A2C6296-25AC-4CD3-BAFE-E225923A4279Q35047128-CE8EB8A3-CE93-455F-B082-484597C8B5C7Q37623517-AD34006E-8F90-456A-B9DE-3052D6E45C77Q38174602-94A5D576-11DF-48C5-92A4-9092F482CD6CQ38909407-1D26B51A-D4C8-46BD-8CFE-64AD7967D3FFQ44810977-FA628006-382D-4885-B064-DFFA95AE3BFBQ47425474-C146F290-3B2B-4A8C-9BCB-0E4CFA5A07A9Q47843877-CCE46E44-0247-4B30-859A-103A2E6853C0Q50991149-0B91AB7F-3F10-42F0-9342-1ED9920C8A90Q53640193-86CA6D45-7248-4C15-A30C-F3F5B78BEA08Q53877436-4810710E-45C5-4EDA-A1FF-F36F0EFD967EQ54568069-26DFD70F-6953-4574-BC5E-56C198EB6BD9Q61409207-DBBEC491-6CFC-4D11-8B80-BEAA9B9E86B6Q61409210-551041DD-B34F-4C04-BE3C-113710503694Q88268030-5DFDF10B-DC54-458C-8F6B-F65684B574EE
P50
description
researcher ORCID ID = 0000-0001-5366-0035
@en
name
Tania Carmenate
@ast
Tania Carmenate
@en
Tania Carmenate
@es
Tania Carmenate
@nl
type
label
Tania Carmenate
@ast
Tania Carmenate
@en
Tania Carmenate
@es
Tania Carmenate
@nl
prefLabel
Tania Carmenate
@ast
Tania Carmenate
@en
Tania Carmenate
@es
Tania Carmenate
@nl
P31
P496
0000-0001-5366-0035